Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease

Rheumatology International

Volumn 31, Issue 8, 2011, Pages 1097-1099

  Aikawa, Nádia Emi ^a   Gonçalves, Carla ^a   Silva, Clovis Artur Almeida ^a   Gonçalves, Célio ^a   Bonfá, Eloísa ^a   De Carvalho, Jozélio Freire ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti TNF ; Beh et's disease; Celiac disease; Cutaneous lesions; Genital ulcers; Oral ulcers

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CELECOXIB; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; NAPROXEN; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTHRITIS; ARTICLE; BEHCET DISEASE; CASE REPORT; CELIAC DISEASE; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA NODOSUM; FASCIITIS; FEMALE; FOLLICULITIS; GENITAL ULCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KNEE ARTHRITIS; MOUTH ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SKIN DEFECT; THROMBOPHLEBITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BEHCET SYNDROME; CELIAC DISEASE; DRUG RESISTANCE; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; ORAL ULCER; RECURRENCE; SKIN DISEASES; TIME FACTORS;

EID: 79961168289     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-009-1276-x     Document Type: Article

References (16)

1. RE Heyman MB Ferraz CR Gonçalves, et al. 1995 Evaluation of the International Study Group for Behçet's Disease Criteria in Brazilian patients Clin Rheumatol 14 526 530 8549090 10.1007/BF02208149 1:STN:280:DyaK287htFWltw%3D%3D
2. PP Sfikakis N Markomichelakis E Alpsoy 2007 Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations Rheumatology (Oxford) 46 736 741 10.1093/rheumatology/kem034 1:CAS:528:DC%2BD2sXntlOjtL0%3D (Pubitemid 47061701)
3. S Ohno S Nakamura S Hori, et al. 2004 Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis J Rheumatol 31 1362 1368 15229958 1:CAS:528:DC%2BD2cXmtlSlt7o%3D (Pubitemid 38879203)
4. M Naganuma A Sakuraba T Hisamatsu, et al. 2008 Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease Inflamm Bowel Dis 14 1259 1264 18393375 10.1002/ibd.20457
5. S Gulli C Arrigo L Bocchino, et al. 2003 Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report BMC Musculoskelet Disord 4 19 12946278 10.1186/1471-2474-4-19
6. M Melikoglu I Fresko C Mat, et al. 2005 Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study J Rheumatol 32 98 105 15630733 1:CAS:528:DC%2BD2MXht1yqsb0%3D (Pubitemid 40092599)
7. G Almoznino E Ben-Chetrit 2007 Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature Clin Exp Rheumatol 25 S99 S102 17949561 1:STN:280: DC%2BD2snntVCmsw%3D%3D
8. M Connolly JS Armstrong DA Buckley 2005 Infliximab treatment for severe orogenital ulceration in Behçet's disease Br J Dermatol 153 1073 1075 16225632 10.1111/j.1365-2133.2005.06914.x 1:STN:280:DC%2BD2MrkvFKhsQ%3D%3D (Pubitemid 41540787)
9. A Sommer P Altmeyer A Kreuter 2005 A case of mucocutaneous Behçet's disease responding to etanercept J Am Acad Dermatol 52 717 719 15793540 10.1016/j.jaad.2004.11.031 (Pubitemid 40585460)
10. JA van Laar T Missotten PL van Daele A Jamnitski GS Baarsma PM van Hagen 2007 Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis 66 565 566 17124248 10.1136/ard.2006.064279 (Pubitemid 46580490)
11. JL Callejas-Rubio D Sánchez-Cano R Ríos-Férnandez N Ortego-Centeno 2008 Treatment of Behçet's disease with adalimumab Med Clin (Barc) 131 438 439 10.1157/13126223
12. International Study Group for Behçet's Disease 1990 Criteria for diagnosis of Behçet's disease Lancet 335 1078 1080
13. FS Neves JC Moraes SC Kowalski C Goldenstein-Schainberg LV Lage CR Gonçalves 2007 Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language Clin Rheumatol 26 1263 1267 17180637 10.1007/s10067-006-0484-y 1:STN:280:DC%2BD2sznvVyhtg%3D%3D (Pubitemid 47034180)
14. H Sarwar H McGrath Jr LR Espinoza 2005 Successful treatment of long-standing neuro-Behçet's disease with infliximab J Rheumatol 32 181 183 15630746 (Pubitemid 40092611)
15. N Sayinalp OI Ozcebe O Ozdemir, et al. 1996 Cytokines in Behçet's disease J Rheumatol 23 321 322 8882039 1:STN:280:DyaK2s%2Fjs1eqsw%3D%3D
16. PJ Anderson 2005 Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles Semin Arthritis Rheum 34 19 22 15852250 10.1016/j.semarthrit.2005.01.005 1:CAS:528:DC%2BD2MXjtVyrtLk%3D